Download Radiation Technology - Comprehensive Cancer Centers of Nevada

C OM PR E H E NS I V E
Radiation Technology
Accelerated Partial Breast Irradiation (APBI), a type
of brachytherapy, is localized treatment that delivers
a highly effective dose of radiation to a specific part
of the breast where the tumor was removed. APBI involves
the insertion of a catheter to kill any cancer cells that may
remain after lumpectomy surgery. This procedure requires
close collaboration between the surgeon who removes the
breast tumor, and the radiation oncologist who treats the
tumor area after surgery.
Accelerated partial breast irradiation is performed
approximately one to four weeks after a lumpectomy. The
device which delivers the radiation remains in place for the
duration of the treatment. The procedure is given twice a
day over a period of five to seven days. This treatment time
is much shorter than external beam radiation which involves
five treatments a week for three and a half to seven weeks.
Comprehensive Cancer Centers of Nevada (CCCN) is accredited by the American College of Radiology,
having earned the accreditation for five consecutive three year terms. Working in tandem with our
advanced treatment planning systems, the purpose of radiation therapy is to eradicate cancerous cells
and to prevent them from growing or dividing, while minimizing adverse effects on nearby healthy organs
and tissues. At CCCN, we offer the most precise radiation applications and state-of-the-art equipment
available, including:
•
•
•
•
•
•
•
•
•
Three-dimensional Conformal Radiation Therapy
Intensity Modulated Radiation Therapy
Image-Guided Radiation Therapy
Volumetric Modulated Arc Therapy
CyberKnife® Radiosurgery
Stereotactic Radiosurgery
High Dose Rate Brachytherapy, Prostate Seed Brachytherapy
Accelerated Partial Breast Irradiation
Clinical Research
CyberKnife® Radiosurgery is exclusive to CCCN and is the most powerful advancement in cancer
treatment ever available in Southern Nevada. Operated by CCCN’s own specially trained radiation
oncologists, CyberKnife can target and eradicate tumors anywhere on the body with incredible precision.
CyberKnife is utilized to treat brain tumors, head and neck tumors, lung tumors, liver lesions, prostate
cancer, spine tumors, previously irradiated tumors and many other hard-to-reach tumor sites.
CyberKnife delivers a much higher dose of radiation in as many as one to five treatments.
In order to spare surrounding healthy tissue from exposure, CyberKnife relies on precision and
accuracy. CyberKnife can be used as an alternative to invasive surgery or weeks of external beam
radiotherapy treatments or can be highly useful as an adjunctive therapy in combination with
conventional radiation therapy or chemotherapy to maximize treatment efficacy.
High Dose Rate Brachytherapy (HDR) uses a radioactive
source that is placed inside the tumor site to be treated.
Then, a high dose of radiation is given to a limited area,
sparing the surrounding normal tissue. HDR brachytherapy
lasts only a few minutes in the outpatient setting and
causes little discomfort, fewer complications, and a quicker
recovery time.
Intensity Modulated Radiation Therapy (IMRT) uses threedimensional imaging to deliver very precise radiation doses
to the tumor while sparing the normal organs. In some tumor
types such as prostate cancer, this technology can deliver
higher doses of radiation therapy while reducing the amount
of radiation exposure to surrounding healthy tissue.
Image-Guided Radiotherapy (IGRT) uses ultrasound, a
CT scan, or X-rays to capture images of the treatment area
before delivering radiation, and is often used to treat cancers
in organs that move, such as the prostate or lung. The use of
the highly precise IGRT treatments result in the surrounding
healthy tissue receiving less radiation exposure while also
reducing radiotherapy side effects.
Stereotactic Radiosurgery (SRS) is ideal for treating brain
tumors and lesions that cannot be treated by traditional
surgical methods. SRS uses a computerguided radiation therapy system
to aim highly-focused beams
of radiation directly into
brain tumors and other brain
abnormalities; the vital areas
of the brain are spared from
the high doses of radiation,
thus decreasing the risk of
side effects. The procedure
is typically performed
in a one-day session on an outpatient basis under local
anesthesia. Patients usually return home shortly after
the procedure.
Volumetric Modulated Arc Therapy (VMAT) uses IMRT and
IGRT to deliver high precision radiation treatments, and can
complete treatments in 30 to 90 seconds.
Groundbreaking Clinical Research at CCCN, where the
practice conducts more than 170 Phase I, Phase II and Phase
III clinical trials each year. As a result of its active research
program, the practice was one of two sites in the United
States that were instrumental in a new groundbreaking
radio-immunotherapy drug that obtained approval from
the Food and Drug Administration. The drug is called Xofigo
(zhō-fi-go) and its active ingredient Radium 223 dichloride,
is a form of ‘liquid radiation’ that fights prostate cancer that
spreads to the bones. It specifically targets prostate cancer
cells that spread to the bone, and leaves unaffected normal
tissues untouched. The latter feature is a breakthrough in
modern medicine since prostate cancer metastasizes to
the bones of many prostate cancer patients. The therapy is
administered intravenously and has multiple advantages
including less pain and fewer side effects. CCCN also offers
other radio-immunotherapies such as Zevalin therapy and
Quadramet therapy. The practice is a leader in conducting
clinical research to offer patients treatment options other
than the typical standard of care.
Radiation Oncology Treatment Centers
N
1
5
N. Hualapai Way
3
2
= Hospital
1
2
4
3
4
5
NORTHWEST
SOUTHWEST
CENTRAL VALLEY
HENDERSON
SUMMERLIN
7445 Peak Drive
Las Vegas, NV 89128
Tel: 702.952.2140
Fax: 702.952.2148
9280 W. Sunset Road
Suite 100
Las Vegas, NV 89148
Tel: 702.952.1251
Fax: 702.952.1241
3730 S. Eastern Avenue
Las Vegas, NV 89169
Tel: 702.952.3400
Fax: 702.952.3713
10001 S. Eastern Avenue
Suite 108
Henderson, NV 89052
Tel: 702.952.3444
Fax: 702.952.3485
655 N. Town Center Drive
Las Vegas, NV 89144
Tel: 702.233.2200
Fax: 702.233.2210
Andrew M. Cohen, MD
Michael T. Sinopoli, MD
Raul T. Meoz, MD, FACR
Michael J. Anderson, MD
Farzaneh Farzin, MD
cccnevada.com • 702.952.3350
Michael J. Anderson, MD
Matthew Schwartz, MD
Dan L. Curtis, MD
Raul T. Meoz, MD, FACR
Michael T. Sinopoli, MD